{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:56:29Z","timestamp":1767135389548,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd002800.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2011,6,15]],"date-time":"2011-06-15T00:00:00Z","timestamp":1308096000000}}],"reference-count":89,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd002800.pub3","type":"journal-article","created":{"date-parts":[[2011,6,7]],"date-time":"2011-06-07T19:19:15Z","timestamp":1307474355000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Propylthiouracil for alcoholic liver disease"],"prefix":"10.1002","author":[{"given":"Giuseppe","family":"Fede","sequence":"first","affiliation":[{"name":"Royal Free Hampstead NHS Foundation Trust; Sheila Sherlock Liver Centre; Pond Street Hampstead London UK NW3 2QG"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giacomo","family":"Germani","sequence":"additional","affiliation":[{"name":"Royal Free Hampstead NHS Foundation Trust; Sheila Sherlock Liver Centre; Pond Street Hampstead London UK NW3 2QG"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Gluud","sequence":"additional","affiliation":[{"name":"Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 3344, Rigshospitalet, Copenhagen University Hospital; Cochrane Hepato-Biliary Group; Blegdamsvej 9 Copenhagen Denmark DK-2100"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kurinchi Selvan","family":"Gurusamy","sequence":"additional","affiliation":[{"name":"Royal Free Campus, UCL Medical School; Department of Surgery; 8th Floor South (Hepatology office) Royal Free Hospital, Pond Street London UK NW3 2QG"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew K","family":"Burroughs","sequence":"additional","affiliation":[{"name":"Royal Free Hampstead NHS Foundation Trust; Sheila Sherlock Liver Centre; Pond Street Hampstead London UK NW3 2QG"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,6,15]]},"reference":[{"issue":"5 II","key":"10.1002\/14651858.CD002800.pub3-BIB0002|cit1","first-page":"1024","article-title":"Propylthiouracil therapy in severe acute alcoholic hepatitis","volume":"79","author":"Halle","year":"1980","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD002800.pub3-BIB0001|cit2","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0016-5085(82)80257-6","article-title":"Double-blind, controlled trial of propylthiouracil in patients with severe acute alcoholic hepatitis","volume":"82","author":"Hall\u00e9","year":"1982","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD002800.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0016-5085(79)80137-7","article-title":"Thyroid hormones in alcoholic liver disease. Effect of treatment with 6-n-propylthiouracil","volume":"76","author":"Israel","year":"1979","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD002800.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0016-5085(82)80050-4","article-title":"Propylthiouracil treatment for alcoholic hepatitis: the case of the missing thirty","volume":"83","author":"Orrego","year":"1982","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD002800.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0016-5085(79)80136-5","article-title":"Effect of short-term therapy with propylthiouracil in patients with alcoholic liver disease","volume":"76","author":"Orrego","year":"1979","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD002800.pub3-BIB0006|cit6","first-page":"1125","article-title":"Chronic propylthiouracil treatment increases survival in patients with alcoholic liver disease","volume":"6","author":"Orrego","year":"1986","journal-title":"Hepatology"},{"issue":"8590","key":"10.1002\/14651858.CD002800.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0140-6736(88)91649-2","article-title":"Long term treatment of alcoholic liver disease with propylthiouracil","volume":"1","author":"Orrego","year":"1988","journal-title":"The Lancet"},{"key":"10.1002\/14651858.CD002800.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1056\/NEJM198712033172301","article-title":"Long-term treatment of alcoholic liver disease with propylthiouracil","volume":"317","author":"Orrego","year":"1987","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD002800.pub3-BIB0009|cit9","first-page":"1471","article-title":"Propylthiouracil for alcoholic liver disease","volume":"318","author":"Orrego","year":"1988","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD002800.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0168-8278(94)80005-7","article-title":"Long-term treatment of alcoholic liver disease with propylthiouracil. Part 2: influence of drop-out rates and of continued alcohol consumption in a clinical trial","volume":"20","author":"Orrego","year":"1994","journal-title":"Journal of Hepatology"},{"issue":"5","key":"10.1002\/14651858.CD002800.pub3-BIB0011|cit11","first-page":"A644","article-title":"Short-term therapy with propylthiouracile (PTU) for alcoholic hepatitis (AH). A clinical, biochemical and histological randomized trial about 25 patients","volume":"96","author":"Pierrugues","year":"1989","journal-title":"Gastoenterology"},{"key":"10.1002\/14651858.CD002800.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1016\/0168-8278(89)90320-6","article-title":"Short-term therapy with propylthiouracile (PTU) for alcoholic hepatitis (AH). A clinical, biochemical and histological randomized trial about 29 patients","volume":"9","author":"Pierrugues","year":"1989","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD002800.pub3-BIB0013|cit13","unstructured":"Rodriguez-Rodriguez E Gonzalez-Reimers E Santolaria-Fernandez F Rodriguez-Moreno F Conde-Martel A Martinez-Riera A Propylthiouracil in acute alcoholic hepatitis II United European Gastroenterology Week Barcelona 1993 A339"},{"issue":"2","key":"10.1002\/14651858.CD002800.pub3-BIB0014|cit14","first-page":"194A","article-title":"Treatment of severe alcoholic hepatitis with propylthiouracil (PTU)","volume":"76","author":"Serrano-Cancino","year":"1981","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD002800.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0168-8278(95)80427-7","article-title":"Vasodilatatory effects of propylthiouracil in patients with alcoholic cirrhosis","volume":"22","author":"Rojter","year":"1995","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD002800.pub3-BIB0016|cit16","first-page":"S64","article-title":"Vasodilatatory effects of propylthiouracil (PTU) in patients with alcoholic cirrhosis (AC)","volume":"16","author":"Rojter","year":"1992","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD002800.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/S0168-8278(97)80429-1","article-title":"Acute effects of propylthiouracil on hemodynamics and oxygen content in patients with alcoholic cirrhosis","volume":"26","author":"Sogni","year":"1997","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD002800.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1053\/gast.2000.20189","article-title":"Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial","volume":"119","author":"Akriviadis","year":"2000","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD002800.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/ije\/dyn188","article-title":"Apparently conclusive meta-analyses may be inconclusive--Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses","volume":"38","author":"Brok","year":"2009","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD002800.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/hep.1840180228","article-title":"Effect of propylthiouracil on the ethanol-induced increase in liver oxygen consumption in awake rats","volume":"18","author":"Carmichael","year":"1993","journal-title":"Hepatology"},{"issue":"2","key":"10.1002\/14651858.CD002800.pub3-BIB0021|cit21","first-page":"128","article-title":"Hepatitis B and hepatitis C virus infection among chronic alcoholic patients with liver disease in Taiwan","volume":"93","author":"Chang","year":"1994","journal-title":"Journal of the Formosan Medical Association"},{"issue":"1","key":"10.1002\/14651858.CD002800.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1136\/gut.37.1.113","article-title":"Glucocorticosteroids are ineffective in alcoholic hepatitis: a meta-analysis adjusting for confounding variables","volume":"37","author":"Christensen","year":"1995","journal-title":"Gut"},{"issue":"4","key":"10.1002\/14651858.CD002800.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/S0168-8278(98)80284-5","article-title":"Attributable risk for symptomatic liver cirrhosis in Italy. Collaborative Groups for the Study of Liver Diseases in Italy","volume":"28","author":"Corrao","year":"1998","journal-title":"Journal of Hepatology"},{"issue":"4","key":"10.1002\/14651858.CD002800.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/hep.510270404","article-title":"Independent and combined action of hepatitis C virus infection and alcohol consumption on the risk of symptomatic liver cirrhosis","volume":"27","author":"Corrao","year":"1998","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD002800.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"845","DOI":"10.3109\/15513819609169310","article-title":"Propylthiouracil-induced fulminant hepatitis: case report and review of the literature","volume":"16","author":"Deidiker","year":"1996","journal-title":"Pediatric Pathology"},{"issue":"3","key":"10.1002\/14651858.CD002800.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/sim.4780060325","article-title":"Methods of combining randomized clinical trials: strengths and limitations","volume":"6","author":"DeMets","year":"1987","journal-title":"Statistics in Medicine"},{"issue":"3","key":"10.1002\/14651858.CD002800.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"issue":"8","key":"10.1002\/14651858.CD002800.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1089\/10507250050137815","article-title":"Acute interstitial nephritis and fatal Stevens-Johnson syndrome after propylthiouracil therapy","volume":"10","author":"Dysseleer","year":"2000","journal-title":"Thyroid"},{"key":"10.1002\/14651858.CD002800.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"2","key":"10.1002\/14651858.CD002800.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1572-0241.1998.00139.x","article-title":"Milk thistle (Silybum marianum) for the therapy of liver disease","volume":"93","author":"Flora","year":"1998","journal-title":"The American Journal of Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD002800.pub3-BIB0031|cit31","first-page":"564","article-title":"Testosterone and alcoholic cirrhosis. Epidemiologic, pathophysiologic and therapeutic studies in men","volume":"35","author":"Gluud","year":"1988","journal-title":"Danish Medical Bullettin"},{"issue":"4","key":"10.1002\/14651858.CD002800.pub3-BIB0032|cit32","first-page":"221","article-title":"Diagnosis and treatment of alcoholic liver disease in Europe","volume":"6","author":"Gluud","year":"1993","journal-title":"Gastroenterology International"},{"key":"10.1002\/14651858.CD002800.pub3-BIB0033|cit33","article-title":"Alcoholic hepatitis: no glucocorticosteroids?","volume-title":"Steatohepatitis (NASH and ASH). FALK Symposium 121","author":"Gluud","year":"2001"},{"key":"10.1002\/14651858.CD002800.pub3-BIB0034|cit34","unstructured":"Gluud C Nikolova D Klingenberg SL Alexakis N Als-Nielsen B Colli A Cochrane Hepato-Biliary Group. About The Cochrane Collaboration (Cochrane Review Groups (CRGs)) 2011, Issue 5. Art. No.: LIVER"},{"key":"10.1002\/14651858.CD002800.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0376-8716(88)90004-X","article-title":"Effect of propylthiouracil on liver cell development in the male albino mouse: protective effect against ethanol-induced alterations","volume":"21","author":"Gonzalez-Reimers","year":"1988","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1002\/14651858.CD002800.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/bjs.6558","article-title":"Assessment of risk of bias in randomized clinical trials in surgery","volume":"96","author":"Gurusamy","year":"2009","journal-title":"British Journal of Surgery"},{"issue":"5","key":"10.1002\/14651858.CD002800.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0016-5085(82)80257-6","article-title":"Double-blind, controlled trial of propylthiouracil in patients with severe acute alcoholic hepatitis","volume":"82","author":"Hall\u00e9","year":"1982","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD002800.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0006-2952(92)90561-V","article-title":"Antioxidant activity of propylthiouracil","volume":"43","author":"Hicks","year":"1992","journal-title":"Biochemical Pharmacology"},{"key":"10.1002\/14651858.CD002800.pub3-BIB0039|cit39","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011] The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org"},{"issue":"3","key":"10.1002\/14651858.CD002800.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/hep.1840180316","article-title":"Increased plasma interleukin-8 concentrations in alcoholic hepatitis","volume":"18","author":"Hill","year":"1993","journal-title":"Hepatology"},{"issue":"7","key":"10.1002\/14651858.CD002800.pub3-BIB0041|cit41","first-page":"1071","article-title":"Sequential liver and bone biochemical changes in hyperthyroidism: prospective controlled follow-up study","volume":"89","author":"Huang","year":"1994","journal-title":"The American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD002800.pub3-BIB0042|cit42","volume-title":"International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. ICH harmonised tripartite guideline. Guideline for good clinical practice1997 CFR & ICH Guidelines","volume":"1","author":"International Conference on Harmonisation Expert Working Group","year":"1997"},{"key":"10.1002\/14651858.CD002800.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s005350050167","article-title":"Propylthiouracil-induced severe hepatitis: a case report and review of the literature","volume":"33","author":"Ichiki","year":"1998","journal-title":"Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD002800.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1530\/acta.0.1120210","article-title":"Inhibitory effects of antithyroid drugs on oxygen radical formation in human neutrophils","volume":"112","author":"Imamura","year":"1986","journal-title":"Acta Endocrinologica"},{"key":"10.1002\/14651858.CD002800.pub3-BIB0045|cit45","unstructured":"Ioannidis JPA Lau J What certainty can there be on how much treatment work? Empirical insight from recursive cumulative meta-analyses 8th International Cochrane Colloquium, October 2000 21"},{"key":"10.1002\/14651858.CD002800.pub3-BIB0046|cit46","first-page":"2052","article-title":"Liver hypermetabolic state after chronic ethanol consumption: hormonal interrelationships and pathogenic implications","volume":"34","author":"Israel","year":"1975","journal-title":"Federation Proceedings"},{"key":"10.1002\/14651858.CD002800.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1073\/pnas.72.3.1137","article-title":"Experimental alcohol-induced hepatic necrosis: suppression by propylthiouracil","volume":"72","author":"Israel","year":"1975","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1002\/14651858.CD002800.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1365-2362.1980.tb00022.x","article-title":"Hepatic vein oxygenation liver blood flow and the rate of ethanol metabolism in recently abstinent patients","volume":"10","author":"Iturriaga","year":"1980","journal-title":"European Journal of Clinical Investigation"},{"key":"10.1002\/14651858.CD002800.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2165\/00003088-198106060-00001","article-title":"Clinical pharmacokinetics of antithyroid drugs","volume":"6","author":"Kampmann","year":"1981","journal-title":"Clinical Pharmacokinetics"},{"key":"10.1002\/14651858.CD002800.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/hep.1840100303","article-title":"Effects of propylthiouracil and methimazole on splanchnic hemodynamics in awake and unrestrained rats","volume":"10","author":"Kawasaki","year":"1989","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD002800.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"982","DOI":"10.7326\/0003-4819-135-11-200112040-00010","article-title":"Reported methodological quality and discrepancies between large and small randomized trials in meta-analyses","volume":"135","author":"Kjaergard","year":"2001","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD002800.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"281","DOI":"10.7326\/0003-4819-121-4-199408150-00010","article-title":"Treatment of hyperthyroid disease","volume":"121","author":"Klein","year":"1994","journal-title":"Annals of Internal Medicine"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD002800.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0168-8278(00)80420-1","article-title":"Alcoholic liver disease: new insights in pathogenesis lead to new treatments","volume":"32","author":"Lieber","year":"2000","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD002800.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1097\/01.ALC.0000093743.03049.80","article-title":"Veterans Affairs Cooperative Study of polyenylphosphatidylcholine in alcoholic liver disease","volume":"27","author":"Lieber","year":"2003","journal-title":"Alcohol Clinical and Experimental Research"},{"issue":"3","key":"10.1002\/14651858.CD002800.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0168-8278(87)80547-0","article-title":"Long-term histological evaluation of the natural history and prognostic factors of alcoholic liver disease","volume":"4","author":"Marbet","year":"1987","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD002800.pub3-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S0168-8278(99)80263-3","article-title":"S-Andenosylmethionine in alcoholic cirrhosis: a randomised, placebo-controlled, double-blind, multicenter clinical trial","volume":"30","author":"Mato","year":"1999","journal-title":"Journal of Hepatology"},{"issue":"23","key":"10.1002\/14651858.CD002800.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJM198412063112302","article-title":"Short-term and long-term survival in patients with alcoholic hepatitis treated with oxandrolone and prednisolone","volume":"311","author":"Mendenhall","year":"1984","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD002800.pub3-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/hep.1840140624","article-title":"Effect of parenteral amino acid supplementation on short-term and long-term outcomes in severe alcoholic hepatitis: a randomised controlled trial","volume":"14","author":"Mezey","year":"1991","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD002800.pub3-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses","volume":"352","author":"Moher","year":"1998","journal-title":"The Lancet"},{"key":"10.1002\/14651858.CD002800.pub3-BIB0060|cit60","first-page":"1185","article-title":"Alcoholic liver disease: natural history, diagnosis, clinical features, evaluation, management, prognosis, and prevention","volume-title":"Oxford Textbook of Clinical Hepatology","volume":"2","author":"Morgan","year":"1999"},{"issue":"4","key":"10.1002\/14651858.CD002800.pub3-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1507\/endocrj.47.467","article-title":"Anti-thyroid drug-induced ANCA-associated vasculitis: a case report and review of the literature","volume":"47","author":"Morita","year":"2000","journal-title":"Endocrine Journal"},{"issue":"1","key":"10.1002\/14651858.CD002800.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0016-5085(79)80136-5","article-title":"Effect of short-term therapy with propylthiouracil in patients with alcoholic liver disease","volume":"76","author":"Orrego","year":"1979","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD002800.pub3-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1056\/NEJM198712033172301","article-title":"Long-term treatment of alcoholic liver disease with propylthiouracil","volume":"317","author":"Orrego","year":"1987","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD002800.pub3-BIB0064|cit64","first-page":"1083","article-title":"Prospective validation of the relationship of the combined clinical and laboratory index, the CCLI, with mortality in alcoholic liver disease","volume":"7","author":"Orrego","year":"1987","journal-title":"Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD002800.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/0002-9343(68)90111-3","article-title":"Duration of survival in patients with Laennec\u00b4s cirrhosis. Influence of alcohol withdrawal, and possible effects of recent changes in general management of the disease","volume":"44","author":"Powell","year":"1968","journal-title":"American Journal of Medicine"},{"issue":"8921","key":"10.1002\/14651858.CD002800.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0140-6736(94)91897-X","article-title":"Evaluation of efficacy of liver transplantation in alcoholic cirrhosis by a case-control study and simulated controls","volume":"344","author":"Poynard","year":"1994","journal-title":"The Lancet"},{"issue":"6","key":"10.1002\/14651858.CD002800.pub3-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/S0168-8278(99)80269-4","article-title":"Evaluation of efficacy of liver transplantation in alcoholic cirrhosis using matched and simulated controls: 5-year survival. Multi-centre group","volume":"30","author":"Poynard","year":"1999","journal-title":"Journal of Hepatology"},{"issue":"2","key":"10.1002\/14651858.CD002800.pub3-BIB0068|cit68","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002148.pub2","article-title":"Colchicine for alcoholic and non-alcoholic liver fibrosis or cirrhosis","author":"Rambaldi","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD002800.pub3-BIB0069|cit69","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003045.pub2","article-title":"Anabolic-androgenic steroids for alcoholic liver disease","author":"Rambaldi","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD002800.pub3-BIB0070|cit70","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002235.pub2","article-title":"S-adenosyl-L-methionine for alcoholic liver diseases","author":"Rambaldi","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD002800.pub3-BIB0071|cit71","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003620.pub3","article-title":"Milk thistle for alcoholic and\/or hepatitis B or C virus liver diseases","author":"Rambaldi","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD002800.pub3-BIB0072|cit72","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2011"},{"issue":"3","key":"10.1002\/14651858.CD002800.pub3-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/S0022-3565(24)37543-3","article-title":"Effect of antithyroid drugs on hydroxyl radical formation a alpha-1-proteinase inhibitor inactivation by neutrophils: therapeutic implications","volume":"285","author":"Ross","year":"1998","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"4","key":"10.1002\/14651858.CD002800.pub3-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1017\/S0266462303000552","article-title":"Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches","volume":"19","author":"Royle","year":"2003","journal-title":"International Journal of Technology Assessment in Health Care"},{"issue":"16","key":"10.1002\/14651858.CD002800.pub3-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1056\/NEJM196804182781602","article-title":"Alcohol-induced hepatic injury in non alcoholic volunteers","volume":"278","author":"Rubin","year":"1968","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD002800.pub3-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"Journal of American Medical Association"},{"issue":"1","key":"10.1002\/14651858.CD002800.pub3-BIB0077|cit77","first-page":"41","article-title":"Circulating and tissue levels of the neutrophil chemotaxin interleukin-8 are elevated in severe acute alcoholic hepatitis, and tissue levels correlate with neutrophil infiltration","volume":"18","author":"Sheron","year":"1993","journal-title":"Hepatology"},{"issue":"8397","key":"10.1002\/14651858.CD002800.pub3-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0140-6736(84)90295-2","article-title":"Prospective evaluation of alcohol abuse and alcoholic liver injury in men as predictors of development of cirrhosis","volume":"2","author":"S\u00f8rensen","year":"1984","journal-title":"The Lancet"},{"issue":"1","key":"10.1002\/14651858.CD002800.pub3-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/ije\/dyn179","article-title":"Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses","volume":"38","author":"Thorlund","year":"2009","journal-title":"International Journal of Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD002800.pub3-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/hep.1840150115","article-title":"Treatment of severe alcoholic hepatitis by infusion of insulin and glucagon: a multicenter sequential trial","volume":"15","author":"Trinchet","year":"1992","journal-title":"Hepatology"},{"issue":"2","key":"10.1002\/14651858.CD002800.pub3-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0197-2456(97)00150-5","article-title":"Do certain countries produce only positive results? A systematic review of controlled trials","volume":"19","author":"Vickers","year":"1998","journal-title":"Controlled Clinical Trials"},{"issue":"1","key":"10.1002\/14651858.CD002800.pub3-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jclinepi.2007.03.013","article-title":"Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis","volume":"61","author":"Wetterslev","year":"2008","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD002800.pub3-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/bmj.39465.451748.AD","article-title":"Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study","volume":"336","author":"Wood","year":"2008","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD002800.pub3-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1016\/0006-2952(87)90211-5","article-title":"Enhancement of hypoxic liver damage by ethanol: involvement of xanthine oxidase and the role of glycolysis","volume":"36","author":"Younes","year":"1987","journal-title":"Biochemical Pharmacology"},{"key":"10.1002\/14651858.CD002800.pub3-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1016\/0006-2952(82)90536-6","article-title":"The swift increase in alcohol metabolism. Inhibition by propylthiouracil","volume":"31","author":"Yuki","year":"1982","journal-title":"Biochemical Pharmacology"},{"issue":"4","key":"10.1002\/14651858.CD002800.pub3-BIB0086|cit86","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002800.pub2","article-title":"Propylthiouracil for alcoholic liver disease","author":"Rambaldi","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD002800.pub3-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1034\/j.1600-0676.2001.210606.x","article-title":"Meta-analysis of propylthiouracil for alcoholic liver disease - a Cochrane Hepato-Biliary Group Review","volume":"21","author":"Rambaldi","year":"2001","journal-title":"Liver"},{"issue":"2","key":"10.1002\/14651858.CD002800.pub3-BIB0088|cit88","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002800.pub2","article-title":"Propylthiouracil for alcoholic liver disease","author":"Rambaldi","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD002800.pub3-BIB0089|cit89","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002800.pub2","article-title":"Propylthiouracil for alcoholic liver disease","author":"Rambaldi","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD002800.pub3\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T19:58:04Z","timestamp":1741204684000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD002800.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Hepato-Biliary Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2011,6,15]]},"references-count":89,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd002800.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,15]]}}}